Taconic Capital Advisors LP

Q3 2024 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Alyssa Yavner - Chief Financial Officer
Location
New York, NY
Holdings as of
30 Sep 2024
Value $
$44.3M
Num holdings
2
Filing time
14 Nov 2025, 13:31:37
Form type
13F-HR/A-4 - New Holdings
Description
Top holdings included ALE and AMED. Request for Confidential Treatment (14 Nov 2024): Confidential Treatment Expired on 14 Nov 2025.
Previous filing
Q2 2024 - 14 Aug 2024
Next filing
Q4 2024 - 14 Feb 2025
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 14 Nov 2024 pursuant to a request for confidential treatment and for which confidential treatment expired on 14 Nov 2025.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Alyssa Yavner Chief Financial Officer New York, New York 14 Nov 2025

Other Included Managers (1):

Num Name Location File Number
1 Taconic Capital Advisors UK LLP London, United Kingdom 028-12491